James Gale
Founding Partner & Managing Director

James Gale is the founding partner of Signet Healthcare Partners. Mr. Gale has over [30] years of healthcare investing and finance experience. 

Mr. Gale is currently the Chairman of the Board of Alpex Pharma S.A. and Teligent (NSDQ: TLGT), and also serves on the Board of Directors of Bionpharma Inc., Chr. Olesen Synthesis A/S, CoreRx Inc, and Spepharm AG.

Prior to founding Signet Healthcare Partners, Mr. Gale was head of principal investment activities and head of investment banking for Gruntal & Co., LLC. While at Gruntal, Mr. Gale’s investment activities included Andrx Corporation, Royce Laboratories (merged with Watson Pharmaceuticals), Lifecell Corporation, Neurocrine Biosciences, and BML Pharmaceuticals (acquired by Endo Pharmaceuticals). 

Prior to joining Gruntal, he originated and managed private equity investments for the Home Insurance Co., Gruntal’s parent. Earlier in his career, Mr. Gale was a senior investment banker at E.F. Hutton & Co. 

Mr. Gale received his Masters of Business Administration from the University of Chicago.

email: james.gale@signethp.com